Reclassification Recommendations for Drug in ‘Magic Mushrooms’ - Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug to a schedule IV drug such as prescription sleep aids, but with tighter control.

Reclassification Recommendations for Drug in ‘Magic Mushrooms’ - Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule I drug to a schedule IV drug such as prescription sleep aids, but with tighter control.: https://ift.tt/2DxyF5p Read more... https://ift.tt/2OUoGrQ